All Stories

  1. Personalized Oncology: Scientific and Technical Approaches
  2. Advances in Cancer Therapeutics and Genomics for Improved Patient Outcomes
  3. Human suicide, clinical treatment overview
  4. Sialic Acids and Cancer: Pathophysiological Association between Metastatic Progress and Treatment
  5. Anticancer Drug Development, Pharmaceutical Progress
  6. Type 2 Diabetes Treatments in Countries of Different Economic Status
  7. Human suicide, biomedical knowledge and therapeutic advances
  8. Human Suicide, an Overview of Management Strategies
  9. COVID-19 Research, Public Health and Biomedical Basis
  10. Human Suicide, Management Landscape
  11. Anticancer Drug Development: Evaluative Architecture
  12. COVID-19 Study: A New Principle Discovery
  13. COVID-19 Study, Diagnostic and Therapeutic Transition
  14. Antimetastatic Drug, Pharmacologic Challenge and Opportunity
  15. Nursery services advances, global campaign
  16. Different approaches to bone transplantation surgery
  17. Bone Metastasis Diagnosis, Blood Biomarker Detections
  18. Anti-metastatic drug development, overview and perspectives
  19. Educational Perspectives for Nursery
  20. Is Tau Molecule Regarded as a Risk Factor for Human Suicide?
  21. Drug Sensitivity Testing for Cancer Therapy, Technique Analysis and Trends
  22. Pulmonary nodules, is there any pathogenesis evidence?
  23. HIV/AIDS Curability Study, Different Approaches and Drug Combination
  24. Pulmonary nodules, surgery or other medication
  25. Bone Metastasis and Circulation Biomarkers Profiling Towards Personalized Cancer Medicine
  26. Pulmonary Nodules, Surgery or Other Medication
  27. Anti-Metastatic Drug Developments, Utility of More Animal Models
  28. Several approaches for anticancer drug development progress
  29. Drug Sensitivity Testing for Cancer Therapy, Key Areas
  30. COVID-19 infection for metabolic abnormal human beings
  31. Fundamental knowledge for nurses 
  32. Nursery promotion, education and system updating
  33. Cancer Bone Metastasis, Diagnostic Insights and Drug Selection
  34. Covid-19 Study, Pathology and Therapeutics
  35. Acupuncture for Bone Disease Treatments, Modern Approaches
  36. Cancer Bone Metastasis, Experimental Study
  37. Neuropsychiatric Approaches for Human Suicide Prediction and Management
  38. Osteoporosis Targeting, Possible Breakthroughs
  39. Neuropsychiatric insights for human suicide
  40. Bone Cancer and Metastasis Trials, Drug Treatment
  41. Neurobiology for human suicide
  42. Bone Disease Treatment Study, Major Pathways
  43. Pathology Study for Human Suicide
  44. Nursery activity and quality, chemistry between doctors and nurses
  45. Nursery education, narrow-range or wide-range
  46. Anticancer drug development, challenge and dilemma
  47. Life Origin on Earth, Knowledge Development
  48. HIV/AIDS treatment, therapeutic strategy break throughs
  49. Nursery education for diabetes
  50. Suicide Risks and Prevention, Neuropathogenic Study
  51. Medical Treatments for Chronic or Aggressive Diseases, Palliative Therapy and Nursery
  52. General information for nursery
  53. Historical analysis of suicide
  54. Drug sensitivity testing, a unique drug selection strategy
  55. Natural drug cancer treatments, strategies from herbal medicine to chemical or biological drugs
  56. Medical treatments for incurable diseases, palliative therapy
  57. Life Origin on Earth, Biochemical Approaches
  58. Nursery training, from technique details in schools into medical knowledge education in nursery career
  59. Herbal medicine in new era
  60. Nursery service, quality promotion
  61. Anti-Metastatic Drug Developments, Biomedical Mechanisms and Therapeutic Categorization
  62. Patient’s care and nursery in different diseases
  63. Ebola Therapeutic Study and Future Directions
  64. New HIV/AIDS Therapeutics
  65. Nursery Service in Modern Days
  66. Nursery Education, Capability and Service Promotion
  67. Nursery Science and Conventions
  68. Cancer Bioinformatics in Cancer Therapy
  69. Individualized Cancer Therapy
  70. Human Suicide Risk and Treatment Study
  71. Type 2 Diabetes Treatment and Drug Development Study
  72. Hypotheses for Life Origin on Earth, Comparison and Validation
  73. Type 2 Diabetes Study, Introduction and Perspective
  74. Type 2 Diabetes Mellitus Study, A Process of Enigma unraveling
  75. Anthocyanins and its biological & therapeutic characters
  76. Diabetes Prevention and Treatments, a Specific Topic for Modern Medicines
  77. A Critical Appraisal of Different Food Safety and Quality Management Tools to Accomplish Food Safety
  78. Pathology and treatments of obesity
  79. Obesity, Risks and Managements
  80. Keep up the pace of drug development evolution and expenditure
  81. An Overview of Obesity
  82. General Topics in the Field of Personalized Cancer Therapy
  83. Human Suicide Risk Study and Treatment: A Mathematical Approach
  84. Anti-Metastatic Drug Developments: Work Out towards New Direction
  85. Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications
  86. Drug Combination in Clinical Cancer Treatments
  87. General outlook for individualized cancer therapy
  88. Ebola origin and treatment
  89. Different Disciplines in the Field of Suicide Study
  90. Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics
  91. HAART in HIV/AIDS Treatments
  92. Anticancer Drug Development, System Updating and Global Participations
  93. Life Origin on Earth, What is the Right Answer?
  94. Life Origin on Earth, What is the Right Answer?
  95. Anticancer Drug Development, Getting out from Bottleneck
  96. Anticancer Drug Development, Getting out from Bottleneck
  97. Human suicide study, major disciplines and treatment outcomes
  98. Anticancer drug development
  99. HIV in Human Genomes and Therapeutics
  100. HIV Biotherapy and Natural Chemotherapeutic Agents
  101. Anticancer Drug Combinations, How Far We can Go Through?
  102. Antimetastatic therapy at aberrant sialylation in cancer cells, a potential hotspot
  103. Life Origin on Earth, Insights among Different Arguments
  104. Genetics in Suicide Treatments, Modern Diagnosis Establishments
  105. Diabetes Preventions and Treatments, a Specific Topic for Modern Medicines
  106. Anticancer Drug Development, Breakthroughs are Waiting
  107. Cancer metastasis treatment, a key drawbacks
  108. The suicide treatment, a new model
  109. HIV Vaccine for Prevention and Cure, A Mission Possible
  110. Zika Therapy
  111. HIV vaccine
  112. Discover Natural Chemical Drugs in Modern Medicines
  113. Mathematics in biomedical science
  114. The origin of HIV
  115. Human suicide study
  116. Mathematics or Physics-Majored Students on the Biomedical Fields, Insiders or Outsiders?
  117. Pharmacogenetics of Cancer Therapy
  118. Anticancer Drug Sensitivity Testing
  119. New Perspectives of HIV/AIDS Therapy Study
  120. Antidepressant treatment study
  121. Clinical neoplasm metastasis treatments according to patient's personal conditions.
  122. Assistant cancer treatments in the clinic
  123. Drug sensitivity testing in clinical cancer treatments
  124. Anticancer drug combination in the clinic
  125. Anticancer drug pharmacogenomics in cancer chemotherapy
  126. Cost-effectiveness for personalized cancer therapy
  127. Conclusion
  128. Introduction
  129. Discussion
  130. Cancer biomarker/bioinformatics detection in clinical cancer treatments
  131. Anti-diabetic treatments
  132. Anticancer Drug Combinational Study
  133. The Origins of HIV
  134. Plasma Fibrinogen Concentrations in Patients with Solid Tumors and Therapeutic Improvements by Combining Anticoagulants or Fibrinolytical Agents
  135. Anticancer Drug Combinations, A Big Momentum is Needed
  136. Anticancer Drug Development, a Matter of Money or a Matter of Idea?
  137. Future Perspectives for Controlling Ebola Epidemics
  138. Ebola Origin and Therapies
  139. Cancer Bioinformatics, its Impacts on Cancer Therapy
  140. Copyright
  141. List of figures and tables
  142. Anti-diabetic treatments, patho-therapeutic relation
  143. Origin of Ebola, hypothesis
  144. Personalized Cancer Therapy: A Perspective
  145. Rethink Of Diabetes Treatment and Drug Development
  146. Pharmacogenomics in human suicide prediction and treatments
  147. Cancer metastasis treatment study and drug developments
  148. Challenge for HIV/AIDS therapy
  149. Cost-effectiveness Considerations of Individualized Cancer Chemotherapy
  150. Drug Combinations in Cancer Treatments
  151. New Insights into Individualized Antimetastatic Therapy
  152. Anticancer drugs on serum sialic acid level in mice bearing LLC
  153. Drug Combinations in Cancer Treatments
  154. Genetics in Neural Toxicity of Drugs
  155. Avian flu, pathogenesis and therapeutic study
  156. First Genetic Information Replication in Life Origin on Earth
  157. Origins of Life, A New Cooperative Model
  158. Cancer Metastases and Clinical Therapies
  159. Origins of Life, RNA world or alternative RNA world
  160. Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids
  161. Individualized Cancer Chemotherapy by Detecting Cancer Biomarkers
  162. Antimetastatic Therapies according to Metastatic Cascade
  163. Genetics in antidepressant-induced suicide
  164. Pathology of Drug-induced mania & suicide
  165. Influenza treatment
  166. High Active Anti-retroviral Therapy for HIV/AIDS, Progresses and Drawback
  167. Individualized cancer chemotherapy
  168. High Active Antiretroviral Therapy for HIV/AIDS-Early Intervention or Later Intervention?
  169. The Hypotheses for the Pathogeny of Drug-Induced Mania and Suicide
  170. The Relationship between Tumor Sialic Acids and Neoplasm Metastasis and as a Drug Target
  171. Genomic study of antidepressant-induced suicide
  172. Aberrant sialylation in tumor cells
  173. Anti-mobility of Bisdioxopiperanes against human mammary tumors
  174. Antimetastatic activity and mechanisms of action of Bisdioxopiperazine compounds
  175. Neural toxicity of drugs
  176. Anticancer activity and mechanisms of Bisdioxopiperazines
  177. Different Spontaneous Pulmonary Metastasis Inhibitions against Lewis Lung Carcinoma in Mice by Bisdioxopiperazine Compounds of Different Treatment Schedules
  178. 14C-probimane in the mice bearing LLC
  179. Unsatisfactory design of human AIDS genome research
  180. Antidepressant in Cancer Treatment
  181. AIDS and human genome studies, from a hypothesis to systematic approaches
  182. Antidepressants in Human suicide
  183. Mathematical model in therapeutic risk prediction
  184. Fibrinogen in neoplasm metastasis
  185. Sequencing the whole genome of infected human cells obtained from diseased patients – a proposed strategy for understanding and overcoming AIDS or other deadest virus-infected diseases
  186. Relationship Between Blood Fibrinogen Concentration and Pathological Features of Cancer Patients: A 139-case Clinical Study
  187. Medicinal Chemistry of Probimane and MST-16: Comparison of Anticancer Effects Between Bisdioxopiperazines
  188. Individualized cancer chemotheray
  189. Anti-proliferative and chromosome segregation by probimane and MST-16
  190. Effect of Anti-Cancer Drugs on the Binding of 125I-Fibrinogen to Two Leukaemia Cell Lines In Vitro
  191. Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo
  192. Inhibition of probimane on lipid peroxidation of rabbit and human erythrocytes
  193. Aberration of sialylation in neoplasm metastasis and possible therapeutics
  194. Effects of Cancer Chemotherapy on the Blood Fibrinogen Concentrations of Cancer Patients
  195. Effect of magnetized water on the mice given high doses of antineoplastic drugs
  196. Inhibition of probimane on lipoperoxidation of human red cells in vitro
  197. Enzyme dynamic study on calmodulin Ca++-Mg++-ATPase system of red blood cells inhibited by α-anordrin and probimane
  198. Journal of Clinical and Medical Reviews